Header Logo

Takemi Tanaka

Concepts (82)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
6
2024
441
3.000
Why?
E-Selectin
3
2016
27
1.160
Why?
SEER Program
1
2024
46
0.970
Why?
Time-to-Treatment
1
2024
26
0.960
Why?
Mastectomy, Segmental
2
2021
18
0.940
Why?
Medicare
1
2024
118
0.930
Why?
Carcinoma, Ductal, Breast
1
2021
15
0.750
Why?
Neoplastic Cells, Circulating
2
2018
24
0.690
Why?
Aptamers, Nucleotide
2
2015
13
0.630
Why?
Leukocytes, Mononuclear
1
2016
73
0.520
Why?
Neoplasm Metastasis
1
2015
151
0.470
Why?
Endothelium, Vascular
1
2016
305
0.440
Why?
Antigens, CD
2
2023
134
0.400
Why?
Gene Expression Regulation, Neoplastic
1
2015
441
0.400
Why?
Female
7
2024
14434
0.390
Why?
Antineoplastic Agents
1
2015
656
0.330
Why?
Membrane Proteins
2
2023
466
0.320
Why?
Cell Line, Tumor
3
2023
1263
0.300
Why?
Humans
9
2024
26789
0.280
Why?
Mice
4
2023
4399
0.280
Why?
Animals
5
2023
9943
0.250
Why?
Cell Adhesion
2
2016
132
0.250
Why?
Mice, Inbred BALB C
2
2016
263
0.240
Why?
Mastectomy
1
2024
21
0.240
Why?
Receptor, ErbB-2
1
2024
32
0.240
Why?
Prognosis
2
2024
759
0.240
Why?
Neoplasms
2
2023
748
0.230
Why?
Biopsy, Needle
1
2023
47
0.230
Why?
Cyclooxygenase 2
1
2023
68
0.220
Why?
Endocytosis
1
2022
81
0.200
Why?
ErbB Receptors
1
2022
96
0.200
Why?
Hormones
1
2021
41
0.190
Why?
Breast
1
2021
51
0.180
Why?
Aged, 80 and over
1
2024
1924
0.170
Why?
Neoplasm Staging
1
2021
456
0.170
Why?
Risk Factors
1
2024
2006
0.170
Why?
Cell Movement
2
2022
352
0.160
Why?
United States
1
2024
2029
0.160
Why?
Retrospective Studies
1
2024
2425
0.150
Why?
Cell Proliferation
2
2022
766
0.150
Why?
Aged
2
2024
5155
0.140
Why?
Carcinoma, Non-Small-Cell Lung
1
2018
102
0.140
Why?
Hyaluronan Receptors
1
2016
29
0.130
Why?
Carcinoma, Squamous Cell
1
2018
152
0.130
Why?
Liver Neoplasms
1
2018
164
0.130
Why?
Tumor Cells, Cultured
1
2016
310
0.130
Why?
Complement C5a
1
2015
5
0.130
Why?
Complement C3a
1
2015
6
0.130
Why?
Aspartate Aminotransferases
1
2015
20
0.130
Why?
Mice, Inbred ICR
1
2015
26
0.130
Why?
Alanine Transaminase
1
2015
25
0.130
Why?
Injections, Intravenous
1
2015
65
0.130
Why?
Transendothelial and Transepithelial Migration
1
2015
5
0.130
Why?
Xenograft Model Antitumor Assays
1
2016
251
0.120
Why?
MCF-7 Cells
1
2015
33
0.120
Why?
Chemical and Drug Induced Liver Injury
1
2015
23
0.120
Why?
Necrosis
1
2015
81
0.120
Why?
Receptors, Estrogen
1
2015
41
0.120
Why?
Drug Administration Schedule
1
2015
218
0.120
Why?
Disease Progression
1
2016
450
0.120
Why?
Genetic Therapy
1
2015
116
0.120
Why?
Lung Neoplasms
1
2018
340
0.110
Why?
Dose-Response Relationship, Drug
1
2015
586
0.110
Why?
Kidney
1
2015
275
0.110
Why?
Mice, Knockout
1
2016
781
0.110
Why?
Risk Assessment
1
2015
586
0.110
Why?
Cytokines
1
2015
439
0.110
Why?
Apoptosis
1
2016
739
0.100
Why?
Liver
1
2015
415
0.100
Why?
Endothelial Cells
1
2015
324
0.100
Why?
Biomarkers
1
2015
731
0.100
Why?
Male
3
2023
12854
0.070
Why?
Immunoglobulins
1
2023
33
0.050
Why?
Tetraspanins
1
2023
36
0.050
Why?
Integrins
1
2022
27
0.050
Why?
Epithelial-Mesenchymal Transition
1
2022
110
0.050
Why?
Tumor Microenvironment
1
2023
143
0.050
Why?
Melanoma
1
2023
140
0.050
Why?
Prostatic Neoplasms
1
2023
270
0.040
Why?
Radionuclide Imaging
1
2018
56
0.040
Why?
Chemoradiotherapy
1
2018
40
0.040
Why?
Survival Rate
1
2018
406
0.030
Why?
Tanaka's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (12)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_